KRP-A218

N/A

Report date: 2023/01/01 09:01:39

Base Information

Drug NameKRP-A218
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionPhosphatidylinositol 4-kinase inhibitorsVirus replication inhibitors
TargetsPhosphatidylinositol 4-kinase
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesKyorin Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKyorin Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A